Position in BIO
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$33,483,449
New position
Shares Held
120,120
first reported quarter
Ownership
0.449%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 99.96087246087247.ToString("F0")%
Shared 0.ToString("F0")%
None 0.03912753912753913.ToString("F0")%
Position in Medical Devices
Healthcare · as of Mar 31, 2026CIBC Bancorp USA Inc. holds $1,374,936,559 across 24 Medical Devices names. BIO ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
4,211,858 | $432,431,459 | |
| 2 | DXCM |
Dexcom Inc
|
4,217,134 | $264,836,014 | |
| 3 | SYK |
Stryker Corp
|
791,285 | $260,008,337 | |
| 4 | BSX |
Boston Scientific Corp
|
1,941,425 | $121,824,418 | |
| 5 | MDT |
Medtronic plc
|
863,257 | $74,801,217 | |
| 6 | ITGR |
Integer Holdings Corp
|
751,764 | $66,155,232 | |
| 7 | NEOG |
Neogen Corp
|
5,993,222 | $55,677,030 | |
| 8 | BIO |
Bio-Rad Laboratories, Inc.
This page
|
120,120 | $33,483,449 |
All Filings in BIO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,483,449 | 120,120 | Shares | Defined | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||